✦ LIBER ✦

A multicentre, randomized, double-blind, placebo-controlled trial of primary cryptococcal meningitis prophylaxis in HIV-infected patients with severe immune deficiency

✍ Scribed by P Chetchotisakd; S Sungkanuparph; B Thinkhamrop; P Mootsikapun; P Boonyaprawit

Book ID: 111063132
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 66 KB
Volume: 5
Category: Article
ISSN: 1464-2662
DOI: 10.1111/j.1468-1293.2004.00201.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Primary prophylaxis of cryptococcal dise

Primary prophylaxis of cryptococcal disease with fluconazole in HIV-positive Ugandan adults: a double-blind, randomised, placebo-controlled trial

✍ Rosalind Parkes-Ratanshi; Katie Wakeham; Jonathan Levin; Deodata Namusoke; James 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 211 KB

A randomized double-blind placebo-contro

A randomized double-blind placebo-controlled add-on trial of lamotrigine in patients with severe epilepsy

✍ J.W.A.S. Sander; P.N. Patsalos; J.R. Oxley; M.J. Hamilton; W.C. Yuen 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 616 KB

Norfloxacin primary prophylaxis of bacte

Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind randomized trial

✍ Jean-Didier Grangie; Dominique Roulot; Gilles Pelletier; Émile-Alexandre Parient 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Rituximab in patients with primary progr

Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial

✍ Kathleen Hawker; Paul O'Connor; Mark S. Freedman; Peter A. Calabresi; Jack Antel 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB 👁 2 views

## Abstract ## Objective Rituximab, a monoclonal antibody selectively depleting CD20+ B cells, has demonstrated efficacy in reducing disease activity in relapsing‐remitting multiple sclerosis (MS). We evaluated rituximab in adults with primary progressive MS (PPMS) through 96 weeks and safety thro

Endocrine effects of oral dehydroepiandr

Endocrine effects of oral dehydroepiandrosterone in men with HIV infection: a prospective, randomized, double-blind, placebo-controlled trial

✍ Leonid Poretsky; David J. Brillon; Stephen Ferrando; Judy Chiu; Martin McElhiney 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 410 KB

Efficacy and safety of topical WBI-1001

Efficacy and safety of topical WBI-1001 in patients with mild to severe atopic dermatitis: results from a 12-week, multicentre, randomized, placebo-controlled double-blind trial

✍ R. Bissonnette; Y. Poulin; Y. Zhou; J. Tan; H.C. Hong; J. Webster; W. Ip; L. Tan 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 336 KB